INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 168 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $321,297 | -91.3% | 6,444 | -90.6% | 0.00% | -100.0% |
| Q2 2022 | $3,696,000 | -59.3% | 68,437 | -44.4% | 0.00% | -50.0% |
| Q1 2022 | $9,084,000 | +84.7% | 123,165 | +212.9% | 0.00% | +33.3% |
| Q4 2021 | $4,917,000 | -16.0% | 39,361 | -7.2% | 0.00% | 0.0% |
| Q3 2021 | $5,853,000 | +1642.0% | 42,423 | +1818.7% | 0.00% | – |
| Q2 2021 | $336,000 | +63.1% | 2,211 | -21.5% | 0.00% | – |
| Q1 2021 | $206,000 | -67.3% | 2,817 | -67.5% | 0.00% | – |
| Q4 2020 | $630,000 | +1025.0% | 8,656 | +221.5% | 0.00% | – |
| Q3 2020 | $56,000 | -84.0% | 2,692 | -81.1% | 0.00% | – |
| Q2 2020 | $350,000 | +11566.7% | 14,268 | +5408.9% | 0.00% | – |
| Q1 2020 | $3,000 | -96.1% | 259 | -95.1% | 0.00% | – |
| Q4 2019 | $77,000 | +48.1% | 5,258 | +32.8% | 0.00% | – |
| Q3 2019 | $52,000 | -17.5% | 3,958 | +3.5% | 0.00% | – |
| Q2 2019 | $63,000 | +384.6% | 3,824 | +406.5% | 0.00% | – |
| Q1 2019 | $13,000 | +116.7% | 755 | +61.3% | 0.00% | – |
| Q4 2018 | $6,000 | -80.0% | 468 | -54.5% | 0.00% | – |
| Q3 2018 | $30,000 | +7.1% | 1,029 | -0.7% | 0.00% | – |
| Q2 2018 | $28,000 | +366.7% | 1,036 | +245.3% | 0.00% | – |
| Q1 2018 | $6,000 | -76.0% | 300 | -76.9% | 0.00% | – |
| Q4 2017 | $25,000 | -83.9% | 1,300 | -79.3% | 0.00% | – |
| Q3 2017 | $155,000 | +22.0% | 6,284 | -20.7% | 0.00% | – |
| Q2 2017 | $127,000 | +1170.0% | 7,922 | +1031.7% | 0.00% | – |
| Q1 2017 | $10,000 | -16.7% | 700 | -9.4% | 0.00% | – |
| Q4 2016 | $12,000 | 0.0% | 773 | +10.4% | 0.00% | – |
| Q3 2016 | $12,000 | – | 700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Discovery Value Fund | 572,950 | $19,990,226 | 5.79% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,145,091 | $39,952,225 | 5.34% |
| MPM BioImpact LLC | 455,238 | $15,883,254 | 4.12% |
| ARK Investment Management | 9,420,782 | $328,691,084 | 2.85% |
| Atlas Venture Associates IX, LLC | 10,000 | $348,900 | 1.74% |
| Ghisallo Capital Management LLC | 250,000 | $8,722,500 | 1.55% |
| Nikko Asset Management Americas, Inc. | 2,976,002 | $103,743,430 | 1.49% |
| Prosight Management, LP | 72,116 | $2,516,127 | 1.37% |
| Rokos Capital Management LLP | 826,063 | $28,391,785 | 1.24% |
| Elmwood Wealth Management, Inc. | 67,899 | $2,368,996 | 1.18% |